Evidence map›Paper›PMID 28884705›Full record

ArticleTurkish journal of haematology : official journal of Turkish Society of Haematology2018

Deena Mohamed Habashy, Deena Samir Eissa, Mona Mahmoud Aboelez

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Turkish journal of haematology : official journal of Turkish Society of Haematology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Integrated Analysis ofBiomolecules · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Expression levels ofAnnals of surgical treatment and research · 2023
    Article
  6. Review
  7. [Chronopharmacology : The right timing can be crucial].Urologie (Heidelberg, Germany) · 2022
    Review
  8. Review
  9. Review
  10. Article
  11. Cancer genomics & proteomics
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Deena Mohamed HabashyAin Shams University Faculty of Medicine, Department of Clinical Pathology, Unit of Hematology, Cairo, Egypt
Deena Samir EissaAin Shams University Faculty of Medicine, Department of Clinical Pathology, Unit of Hematology, Cairo, Egypt
Mona Mahmoud AboelezAin Shams University Faculty of Medicine, Department of Clinical Pathology, Unit of Hematology, Cairo, Egypt
Ain Shams University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Traditional prognostic factors have proved insufficient to account for heterogeneity in the clinical behavior of chronic lymphocytic leukemia (CLL). Materials and Methods: A total of 100 CLL patients at diagnosis were studied for Results: Conclusion:

Indexed as

AgedBiomarkers, TumorCohort StudiesCryptochromesDisease ProgressionEgyptFemaleGene ExpressionHumansLeukemia, Lymphocytic, Chronic, B-CellMaleMiddle AgedPrognosisProspective StudiesBiomarkers, TumorCRY1 protein, humanCryptochromesCD38Chronic lymphocytic leukemiaCircadian genesCryptochrome-1PrognosisReal-time polymerase chain reactionTime to first treatmentZap-70

Identifiers

PMID28884705
PMCPMC6110451
OpenAlexW2751324669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.